This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Serena, C.
Right arrow Articles by Guarro, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Serena, C.
Right arrow Articles by Guarro, J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, July 2004, p. 2724-2726, Vol. 48, No. 7
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.7.2724-2726.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

In Vitro Antifungal Susceptibilities of Uncommon Basidiomycetous Yeasts

Carolina Serena,1 Francisco Javier Pastor,1 Montserrat Ortoneda,1 Javier Capilla,1 Nicole Nolard,2 and Josep Guarro1*

Unitat de Microbiologia, Facultat de Medicina i Ciencies de la Salut, Universitat Rovira i Virgili, Reus, Spain,1 Scientific Institute of Public Health, Brussels, Belgium2

Received 22 December 2003/ Returned for modification 24 January 2004/ Accepted 5 March 2004

The in vitro activities of eight antifungal drugs against 50 isolates of basidiomycetous yeasts were determined by a microdilution method. In general fluconazole and micafungin were inactive. Terbinafine was active only against Sporobolomyces salmonicolor. The activities of the other antifungals were variable and depended on the species tested. The new triazoles showed the lowest MICs, but amphotericin B and itraconazole were the only drugs active against Cryptococcus albidus.

* Corresponding author. Mailing address: Unitat de Microbiologia, Facultat de Medicina, Universitat Rovira i Virgili, Carrer Sant Llorenç, 21.43201 Reus, Spain. Phone: 977-759359. Fax: 977-759322. E-mail: umb{at}fmcs.urv.es.

Antimicrobial Agents and Chemotherapy, July 2004, p. 2724-2726, Vol. 48, No. 7
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.7.2724-2726.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Leaw, S. N., Chang, H. C., Barton, R., Bouchara, J.-P., Chang, T. C. (2007). Identification of Medically Important Candida and Non-Candida Yeast Species by an Oligonucleotide Array. J. Clin. Microbiol. 45: 2220-2229 [Abstract] [Full Text]  
  • Serena, C., Gilgado, F., Marine, M., Pastor, F. J., Guarro, J. (2006). Efficacy of voriconazole in a Guinea pig model of invasive trichosporonosis.. Antimicrob. Agents Chemother. 50: 2240-2243 [Abstract] [Full Text]  
  • Serena, C., Fernandez-Torres, B., Pastor, F. J., Trilles, L., Lazera, M. d. S., Nolard, N., Guarro, J. (2005). In Vitro Interactions of Micafungin with Other Antifungal Drugs against Clinical Isolates of Four Species of Cryptococcus. Antimicrob. Agents Chemother. 49: 2994-2996 [Abstract] [Full Text]  
  • Gomez-Lopez, A., Mellado, E., Rodriguez-Tudela, J. L., Cuenca-Estrella, M. (2005). Susceptibility profile of 29 clinical isolates of Rhodotorula spp. and literature review. J Antimicrob Chemother 55: 312-316 [Abstract] [Full Text]  
  • Serena, C., Pastor, F. J., Gilgado, F., Mayayo, E., Guarro, J. (2005). Efficacy of Micafungin in Combination with Other Drugs in a Murine Model of Disseminated Trichosporonosis. Antimicrob. Agents Chemother. 49: 497-502 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»